Cybin (HELP) Profit After Tax (2020 - 2025)
Cybin (HELP) reported Profit After Tax of -$17763.5 for Q2 2025, down 124.25% on a YoY basis from $73241.3 in Q2 2024, and up 99.98% quarter-over-quarter from -$78.8 million in Q1 2025.
Cybin (HELP) Profit After Tax (2020 - 2025) Analysis & Trends
Cybin has reported Profit After Tax for 6 years, with the latest figure at -$17763.5 in Q2 2025.
- For the quarter ending Q2 2025, Profit After Tax fell 124.25% year-over-year to -$17763.5; the trailing twelve-month figure through Jun 2025 stood at -$120.7 million (down 1091.23% YoY), and the FY2025 full-year result was -$81.4 million, down 40.46% from the prior year.
- Profit After Tax for Q2 2025 stood at -$17763.5, up from -$78.8 million in the prior quarter.
- The five-year high for Profit After Tax was $32.0 million in Q1 2022, with the low at -$78.8 million in Q1 2025.
- Historically, Profit After Tax has averaged -$8.3 million across 5 years, with a median of -$7.8 million in 2022.
- Annual changes were most pronounced in 2024 — Profit After Tax surged 99.93% — and 2025, when it sank 6272.7%.
- Cybin's Profit After Tax stood at -$13.7 million in 2021, then jumped by 42.04% to -$7.9 million in 2022, then soared by 99.72% to -$22278.5 in 2023, then jumped by 66.13% to -$7546.5 in 2024, then tumbled by 135.39% to -$17763.5 in 2025.
- The last three Profit After Tax figures came in at -$17763.5 (Q2 2025), -$78.8 million (Q1 2025), and -$7546.5 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.63 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -56.74 Mn |
| 10 | Cybin | 75.42 Mn | 75.42 Mn | - | -17,763.51 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -17,763.51 |
| Mar 31, 2025 | -78.79 Mn |
| Dec 31, 2024 | -7,546.48 |
| Sep 30, 2024 | -41.92 Mn |
| Jun 30, 2024 | -7,921.18 |
| Mar 31, 2024 | -1.24 Mn |
| Dec 31, 2023 | -22,278.46 |
| Sep 30, 2023 | -8.87 Mn |
| Jun 30, 2023 | -10.80 Mn |
| Feb 28, 2023 | 19.80 Mn |
| Dec 31, 2022 | -7.91 Mn |
| Sep 30, 2022 | -7.65 Mn |
| May 31, 2022 | 4.55 Mn |
| Feb 28, 2022 | 32.01 Mn |
| Dec 31, 2021 | -13.65 Mn |
| Sep 30, 2021 | -13.99 Mn |
| Jun 30, 2021 | -11.97 Mn |
| Mar 31, 2021 | -9.77 Mn |
| Dec 31, 2020 | -8.76 Mn |
| Sep 30, 2020 | -2.00 Mn |